Menu
"I see ISCTR as an organization focused on delivering education to drive innovation that has the best chance of yielding genuine clinical benefit. It is an honor for me to have this award named after me."
The ISCTR mission is to expedite scientific discovery by providing education in innovation and translation to bring new concepts into new therapies that improve human health.
Dr. John B. Simpson exemplifies this mission through his creativity and the development of therapies that have improved the lives of patients worldwide. His invention and commercialization of the first over-the-wire balloon catheter used for percutaneous transluminal coronary angioplasty (PTCA) enabled interventional cardiology as it is practiced today.
Dr. Simpson founded ACS and DVI (both acquired by Eli Lilly), CVIS (acquired by Boston Scientific), Perclose (sold to Abbott), Lumend (acquired by Cordis), and Fox Hollow (acquired by ev3 which is now part of Medtronic).
Dr. Simpson received his PhD in Immunology from the University of Texas, his MD from Duke University, and completed his fellowship in interventional cardiology at Stanford University. He is a member of the American College of Physicians, a fellow of the American College of Cardiology, has published on a wide variety of medical subjects, and has lectured extensively throughout the world.
The ISCTR is privileged and proud to name the ISCTR award, “The John B. Simpson Award for Major Contributions to Innovation and Translation in Cardiovascular Devices.” The award will be given to individuals whose contributions have impacted human lives significantly.
Antonio Colombo is Senior Consultant at Humanitas Clinical Research Hospital, in Milan, Italy and Director of Cardiac Catheterization Laboratory in Columbus Hospital in Milan, Italy. Prof. Antonio Colombo has been General Coordinator of GVM- Care and Research Group, Cardiac Laboratories in Italy for the past two years and Director of Invasive Cardiology at San Raffaele Scientific Institute and Professor of Cardiology at University Vita e Salute in Milan for the past 20 years.
Prof. Colombo performed landmark work in the field of coronary stenting, intravascular ultrasound and stent thrombosis. He has been one of the early initiators of TAVI procedures in Italy refining some aspect of this procedure. Antonio Colombo is on the Editorial Board of all major Cardiology and Interventional Cardiology Journals. He received several recognitions including the TCT Career Achievement Award and the PCR Ethica Award.
He published over 1000 papers in peer review journals, several books in the field of coronary interventions and contributed with chapters in the most important Interventional Cardiology books
2023
